208 related articles for article (PubMed ID: 24314397)
1. Inhibition of serine and proline racemases by substrate-product analogues.
Harty M; Nagar M; Atkinson L; Legay CM; Derksen DJ; Bearne SL
Bioorg Med Chem Lett; 2014 Jan; 24(1):390-3. PubMed ID: 24314397
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of glutamate racemase by substrate-product analogues.
Pal M; Bearne SL
Bioorg Med Chem Lett; 2014 Mar; 24(5):1432-6. PubMed ID: 24507924
[TBL] [Abstract][Full Text] [Related]
3. Potent inhibition of mandelate racemase by a fluorinated substrate-product analogue with a novel binding mode.
Nagar M; Lietzan AD; St Maurice M; Bearne SL
Biochemistry; 2014 Feb; 53(7):1169-78. PubMed ID: 24472022
[TBL] [Abstract][Full Text] [Related]
4. Substrate-product analogue inhibitors of isoleucine 2-epimerase from Lactobacillus buchneri by rational design.
Sorbara NT; MacMillan JWM; McCluskey GD; Bearne SL
Org Biomol Chem; 2019 Sep; 17(37):8618-8627. PubMed ID: 31528932
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of mandelate racemase by the substrate-intermediate-product analogue 1,1-diphenyl-1-hydroxymethylphosphonate.
Burley RK; Bearne SL
Bioorg Med Chem Lett; 2005 Oct; 15(19):4342-4. PubMed ID: 16039120
[TBL] [Abstract][Full Text] [Related]
6. Expanding the chemical space of human serine racemase inhibitors.
Dellafiora L; Marchetti M; Spyrakis F; Orlandi V; Campanini B; Cruciani G; Cozzini P; Mozzarelli A
Bioorg Med Chem Lett; 2015 Oct; 25(19):4297-303. PubMed ID: 26283510
[TBL] [Abstract][Full Text] [Related]
7. Potent dialkyl substrate-product analogue inhibitors and inactivators of α-methylacyl-coenzyme A racemase from Mycobacterium tuberculosis by rational design.
Pal M; Easton NM; Yaphe H; Bearne SL
Bioorg Chem; 2018 Apr; 77():640-650. PubMed ID: 29502025
[TBL] [Abstract][Full Text] [Related]
8. Malonate-based inhibitors of mammalian serine racemase: kinetic characterization and structure-based computational study.
Vorlová B; Nachtigallová D; Jirásková-Vaníčková J; Ajani H; Jansa P; Rezáč J; Fanfrlík J; Otyepka M; Hobza P; Konvalinka J; Lepšík M
Eur J Med Chem; 2015 Jan; 89():189-97. PubMed ID: 25462239
[TBL] [Abstract][Full Text] [Related]
9. A new strategy to decrease N-methyl-D-aspartate (NMDA) receptor coactivation: inhibition of D-serine synthesis by converting serine racemase into an eliminase.
Panizzutti R; De Miranda J; Ribeiro CS; Engelender S; Wolosker H
Proc Natl Acad Sci U S A; 2001 Apr; 98(9):5294-9. PubMed ID: 11309496
[TBL] [Abstract][Full Text] [Related]
10. In silico and pharmacological screenings identify novel serine racemase inhibitors.
Mori H; Wada R; Li J; Ishimoto T; Mizuguchi M; Obita T; Gouda H; Hirono S; Toyooka N
Bioorg Med Chem Lett; 2014 Aug; 24(16):3732-5. PubMed ID: 25066953
[TBL] [Abstract][Full Text] [Related]
11. Occurrence of pyridoxal 5'-phosphate-dependent serine racemase in silkworm, Bombyx mori.
Uo T; Yoshimura T; Shimizu S; Esaki N
Biochem Biophys Res Commun; 1998 May; 246(1):31-4. PubMed ID: 9600063
[TBL] [Abstract][Full Text] [Related]
12. Catalytic mechanism and properties of pyridoxal 5'-phosphate independent racemases: how enzymes alter mismatched acidity and basicity.
Fischer C; Ahn YC; Vederas JC
Nat Prod Rep; 2019 Dec; 36(12):1687-1705. PubMed ID: 30994146
[TBL] [Abstract][Full Text] [Related]
13. Dual substrate and reaction specificity in mouse serine racemase: identification of high-affinity dicarboxylate substrate and inhibitors and analysis of the beta-eliminase activity.
Strísovský K; Jirásková J; Mikulová A; Rulísek L; Konvalinka J
Biochemistry; 2005 Oct; 44(39):13091-100. PubMed ID: 16185077
[TBL] [Abstract][Full Text] [Related]
14. Serine racemase with catalytically active lysinoalanyl residue.
Yamauchi T; Goto M; Wu HY; Uo T; Yoshimura T; Mihara H; Kurihara T; Miyahara I; Hirotsu K; Esaki N
J Biochem; 2009 Apr; 145(4):421-4. PubMed ID: 19155267
[TBL] [Abstract][Full Text] [Related]
15. Rational design and synthesis of substrate-product analogue inhibitors of α-methylacyl-coenzyme A racemase from Mycobacterium tuberculosis.
Pal M; Khanal M; Marko R; Thirumalairajan S; Bearne SL
Chem Commun (Camb); 2016 Feb; 52(13):2740-3. PubMed ID: 26759836
[TBL] [Abstract][Full Text] [Related]
16. Cyclopropane derivatives as potential human serine racemase inhibitors: unveiling novel insights into a difficult target.
Beato C; Pecchini C; Cocconcelli C; Campanini B; Marchetti M; Pieroni M; Mozzarelli A; Costantino G
J Enzyme Inhib Med Chem; 2016 Aug; 31(4):645-52. PubMed ID: 26133542
[TBL] [Abstract][Full Text] [Related]
17. D-amino acids in the brain: the biochemistry of brain serine racemase.
Baumgart F; Rodríguez-Crespo I
FEBS J; 2008 Jul; 275(14):3538-45. PubMed ID: 18564178
[TBL] [Abstract][Full Text] [Related]
18. Design and evaluation of substrate-product analog inhibitors for racemases and epimerases utilizing a 1,1-proton transfer mechanism.
Bearne SL
Methods Enzymol; 2023; 690():397-444. PubMed ID: 37858537
[TBL] [Abstract][Full Text] [Related]
19. D-amino acids in the brain: structure and function of pyridoxal phosphate-dependent amino acid racemases.
Yoshimura T; Goto M
FEBS J; 2008 Jul; 275(14):3527-37. PubMed ID: 18564179
[TBL] [Abstract][Full Text] [Related]
20. Human serine racemase structure/activity relationship studies provide mechanistic insight and point to position 84 as a hot spot for β-elimination function.
Nelson DL; Applegate GA; Beio ML; Graham DL; Berkowitz DB
J Biol Chem; 2017 Aug; 292(34):13986-14002. PubMed ID: 28696262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
